Responder rates at Week 52 in QUEST (secondary endpoint)1,2,a,b
EOS ≥300 cells/μL - QUEST
with DUPIXENT 200 mg + SOC
vs 67% with placebo + SOC
(OR: 1.46 [95% CI: 0.90, 2.35])
with DUPIXENT 300 mg +
SOC vs 64% with placebo + SOC (OR: 1.39 [95% CI: 0.88, 2.19])
EOS ≥300 cells/μL - QUEST
with DUPIXENT 200 mg + SOC
vs 55% with placebo + SOC
(OR: 2.02 [95% CI: 1.24, 3.32])
with DUPIXENT 300 mg + SOC
vs 55% with placebo + SOC
(OR: 1.79 [95% CI: 1.13, 2.85])